Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.85
+0.11 (0.75%)
Feb 3, 2026, 2:45 PM CST

SHA:600535 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,6032,9944,4513,1192,3041,976
Trading Asset Securities
886.32524.72300.711,1251,487142.92
Cash & Short-Term Investments
3,4893,5184,7514,2443,7912,119
Cash Growth
-29.77%-25.95%11.95%11.95%78.94%8.63%
Accounts Receivable
2,7371,9662,1313,3483,7965,198
Other Receivables
35.7923.0611.498.989.47421.43
Receivables
2,7721,9892,1423,3573,8055,619
Inventory
1,4291,7121,7481,5321,5481,354
Other Current Assets
109.3191.7291.43127.08105145.92
Total Current Assets
7,8007,3118,7339,2609,2499,237
Property, Plant & Equipment
3,5023,6483,7693,8834,0883,881
Long-Term Investments
1,4691,8212,0541,5111,2291,535
Goodwill
--15.8815.88167.0815.88
Other Intangible Assets
779.33604.17573.64459.43474.54361.4
Long-Term Deferred Tax Assets
49.1853.175088.2960.7942.82
Long-Term Deferred Charges
1,3061,4661,4761,1571,1931,412
Other Long-Term Assets
52.1872.5443.14102.0879.688.45
Total Assets
14,95714,97616,71416,47716,54216,494
Accounts Payable
329.26606.81572.73887.77728.58572.52
Accrued Expenses
240.01171.05178.38242.79213.15200.28
Short-Term Debt
464.76710.95814.63201.77188.79638.73
Current Portion of Long-Term Debt
166.3586.83462.74475.21343.331,137
Current Portion of Leases
-47.8458.5453.9855.67-
Current Income Taxes Payable
138.7857.7818.0484.62108.0934.6
Current Unearned Revenue
52.8769.8591.6292.3568.3326.82
Other Current Liabilities
647.2398.58172.88108.72149.12221.86
Total Current Liabilities
2,0392,3502,3702,1471,8552,832
Long-Term Debt
178.84253.761,4141,3761,0341,020
Long-Term Leases
47.1367.9781.5275.3181.63-
Long-Term Unearned Revenue
191.66193.29159.02177.79214.57234.56
Long-Term Deferred Tax Liabilities
0.40.40.1122.8742.1822.55
Total Liabilities
2,4572,8654,0243,7993,2284,109
Common Stock
1,4941,4941,5001,5001,5131,513
Additional Paid-In Capital
472.37458.96958.081,4571,5302,321
Retained Earnings
10,2709,8989,9299,35110,2228,359
Treasury Stock
---105.98-105.98-251.29-194.86
Comprehensive Income & Other
68.0452.2288211.58-32.19-25.1
Total Common Equity
12,30411,90312,36812,41212,98111,972
Minority Interest
195.66207.86321.59265.12332.56411.77
Shareholders' Equity
12,50012,11112,69012,67813,31412,384
Total Liabilities & Equity
14,95714,97616,71416,47716,54216,494
Total Debt
857.031,6672,8312,1821,7042,796
Net Cash (Debt)
2,6321,8511,9202,0622,088-677.47
Net Cash Growth
-5.91%-3.59%-6.89%-1.23%--
Net Cash Per Share
1.771.241.291.401.39-0.45
Filing Date Shares Outstanding
1,4941,4941,4941,4941,4991,503
Total Common Shares Outstanding
1,4941,4941,4941,4941,4991,503
Working Capital
5,7604,9616,3637,1137,3946,406
Book Value Per Share
8.247.978.288.318.667.97
Tangible Book Value
11,52511,29911,77911,93712,34011,595
Tangible Book Value Per Share
7.717.567.887.998.237.71
Buildings
-3,5173,5053,4903,3983,239
Machinery
-3,7633,6253,4723,3402,974
Construction In Progress
-221.76153.87102.96167.85400.97
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.